KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Enterprise Value (2016 - 2025)

Boston Scientific (BSX) has disclosed Enterprise Value for 17 consecutive years, with -$1.7 billion as the latest value for Q4 2025.

  • Quarterly Enterprise Value fell 853.59% to -$1.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.7 billion through Dec 2025, down 853.59% year-over-year, with the annual reading at -$1.7 billion for FY2025, 853.59% down from the prior year.
  • Enterprise Value hit -$1.7 billion in Q4 2025 for Boston Scientific, down from -$1.0 billion in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$167.0 million in Q2 2023 to a low of -$2.7 billion in Q2 2021.
  • Historically, Enterprise Value has averaged -$1.1 billion across 5 years, with a median of -$818.5 million in 2022.
  • Biggest five-year swings in Enterprise Value: skyrocketed 89.68% in 2022 and later tumbled 1501.8% in 2024.
  • Year by year, Enterprise Value stood at -$1.9 billion in 2021, then skyrocketed by 51.79% to -$928.0 million in 2022, then soared by 33.51% to -$617.0 million in 2023, then surged by 70.66% to -$181.0 million in 2024, then crashed by 853.59% to -$1.7 billion in 2025.
  • Business Quant data shows Enterprise Value for BSX at -$1.7 billion in Q4 2025, -$1.0 billion in Q3 2025, and -$299.0 million in Q2 2025.